Atrás
Rango del Día
$24.96
$26.38
Rango de 52 Semanas
$9.98
$29.65
Volumen
2,089,481
Promedio 50D / 200D
$21.55
/
$17.77
Cierre Anterior
$24.82
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -8.4 | 0.4 |
| P/B | 11.1 | 2.9 |
| ROE % | -97.9 | 3.8 |
| Net Margin % | -20.2 | 3.9 |
| Rev Growth 5Y % | 9.6 | 10.0 |
| D/E | 2.9 | 0.2 |
Puntos Clave
Revenue grew 9.62% annually over 5 years — modest growth
Debt/Equity of 2.86 — high leverage
Negative free cash flow of -29.67M
Capital efficient — spends only 1.97% of revenue on capex
Crecimiento
Revenue Growth (5Y)
9.62%
Revenue (1Y)7.93%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-97.88%
ROIC-9.77%
Net Margin-20.17%
Op. Margin-7.70%
Seguridad
Debt / Equity
2.86
Current Ratio2.55
Interest Coverage-9.88
Valoración
P/E Ratio
-8.37
P/B Ratio11.05
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.93% | Revenue Growth (3Y) | 16.50% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9.62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.01B | Net Income (TTM) | -204.71M |
| ROE | -97.88% | ROA | -23.23% |
| Gross Margin | 52.31% | Operating Margin | -7.70% |
| Net Margin | -20.17% | Free Cash Flow (TTM) | -29.67M |
| ROIC | -9.77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.86 | Current Ratio | 2.55 |
| Interest Coverage | -9.88 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -8.37 | P/B Ratio | 11.05 |
| P/S Ratio | 1.69 | PEG Ratio | -0.07 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.71B | Enterprise Value | 2.07B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.01B | 940.20M | 747.72M | 801.22M | 702.80M |
| Net Income | -204.71M | -96.03M | -222.61M | -94.59M | 15.57M |
| EPS (Diluted) | -3.04 | -1.47 | -3.43 | -1.47 | 0.24 |
| Gross Profit | 530.85M | 489.57M | 367.69M | 412.99M | 376.22M |
| Operating Income | -78.12M | -99.13M | -233.23M | -92.85M | 22.65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 881.11M | 967.66M | 952.66M | 1.05B | 905.14M |
| Total Liabilities | 725.94M | 704.56M | 639.03M | 612.84M | 472.03M |
| Shareholders' Equity | 155.17M | 263.10M | 313.63M | 439.95M | 433.11M |
| Total Debt | 444.48M | 473.57M | 415.67M | 419.88M | 314.67M |
| Cash & Equivalents | 90.63M | 69.23M | 58.87M | 172.52M | 71.18M |
| Current Assets | 618.14M | 724.49M | 747.99M | 849.98M | 811.52M |
| Current Liabilities | 242.72M | 247.05M | 195.26M | 165.29M | 131.86M |